Novel Drugs to Cure Chronic Hepatitis B

Novira is developing an exciting
pipeline of therapeutics for CHB

Chronic Hepatitis B

CHB is a major healthcare problem
affecting millions of people worldwide

NVR-1221

Our lead clinical candidate has a novel
mechanism of action to disrupt the HBV lifecycle

1
1

ABOUT NOVIRA

Our team is focused on developing innovative therapies for Hepatitis B.


HBV LIFECYCLE

Our antiviral therapeutics seek to disrupt multiple steps in the Hepatitis B virus lifecycle.


THE NOVIRA APPROACH

We are developing novel antivirals with new mechanisms of action to provide a functional cure for chronic Hepatitis B.


NEWS & EVENTS

We are conducting a Phase 1 clinical study of NVR-1221, our lead HBV core inhibitor.